OPEN END TURBO PUT WARRANT - ELI LILLY & CO | Market Closed - Bid/Ask 01:25:55 2024-06-27 pm EDT | After market 02:52:52 pm | |||
| 4.86 EUR | -8.82% |
|
4.82 | -0.82% |
| Current month | -62.67% | ||
| 1 month | -62.99% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
ELI LILLY AND COMPANY
Latest news about ELI LILLY AND COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 24-06-27 | 4.86 | -8.82% |
| 24-06-26 | 5.33 | +7.46% |
| 24-06-25 | 4.96 | -8.15% |
| 24-06-24 | 5.4 | -17.43% |
| 24-06-21 | 6.54 | +27.73% |
Real-time Boerse Frankfurt Warrants
Last update June 27, 2024 at 01:25 pm EDT
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | ELI LILLY AND COMPANY |
| Issuer | UBS |
| WKN | UM0GHA |
| ISIN | DE000UM0GHA1 |
| Date issued | 2024-01-18 |
| Strike | 954.7 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 29.55 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 31.59 € |
|---|---|
| Lowest since issue | 4.32 € |
| Spread | 0.06 € |
| Spread % | 1.24% |
Company Profile
Eli Lilly and Company is one of the world's leading pharmaceutical groups. Net sales break down by therapeutic field as follows:
- endocrinology (57.7%): products for treating osteoporosis, diabetes, and growth problems;
- oncology (19.5%);
- immunology diseases (11.1%);
- neurology (8.4%): primarily drugs used in treating depression and schizophrenia;
- other (3.3%).
Net sales are distributed geographically as follows: the United States (63.9%), Europe (18.1%), Japan (4.9%), China (4.5%) and other (8.6%).
Sector
-
Consensus: Eli Lilly and Company
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
901.3
USD
Average target price
860.5
USD
Spread / Average Target
-4.52%
- Stock Market
- Certificates
- Certificat
